Hansoh Pharmaceutical (3692) Nyalo Cwiny me Stock
AI forecast: 3692
AI otyeko kwena ya ceng ma lwenyo, gima agik juma, ki gima agik juma. Kwena en gima iyar ki neno kwena ma nyaka. Gin en neno ki kare, onyo nyutu ya yat.
Jaji e lweny e dwe 6 mag giko
Premium nyalo neno ceng'a AI me yweyo piyo ki 1 odiiyo, 1 juma ki 1 dwe ki gima onongo ki gikato ma okato.
Unlock Premium🔒 Nyinge yoo oryeto
Neno kare duto — forecast duto ma otyeko ki kwena ma otyeko — en pake Premium.
Unlock PremiumNyinge Aciya Man
Hansoh Pharmaceutical is among the top 30 pharmaceutical companies in China. The company manufactures medicines and has 20 years of experience in research for the treatment of diseases, including cancer, diabetes, and nervous system disorders. By the end of 2020, the company had carried out more than 50 national research and development projects and obtained over 300 invention patents in China and abroad. It owns R&D centers in Shanghai, Changzhou, and Lianyungang (China), as well as in Maryland (United States).
